Sign in
Taking people in United KingdomNo phase

Registry Tracking Endoscopic Treatments for Obesity and Type 2 Diabetes Across the UK

Follows adults with obesity or type 2 diabetes who receive endoscopic weight-loss procedures.

Key facts

Who runs it
Cleveland Clinic London
Where
London, United KingdomSee the site
Trial code
Registry title
A UK Registry for Metabolic and Bariatric Endoscopic Interventions
Status
Recruiting
People taking part
300 people, planned
Started
1 Feb 2024
Expected to end
1 Feb 2039
Type of study
Observational, 3 groups
Treatments tested
  • Endoscopic gastric suturing
  • Endoscopic gastric plication
  • Revisional gastroplasty
  • Transoral outlet reduction endoscopy (TORe)
  • Duodenal mucosal resurfacing (DMR)
  • Intragastric balloon(s)
Record updated
15 March 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for adults who are having a first-time or repeat weight-loss or metabolic procedure done with an endoscope in the UK.

Age
18 years or older (up to 99 years)
Sex
All sexes can join.
Earlier treatment
People can have a first (primary) or a repeat (revisional) endoscopic weight-loss or metabolic procedure.

Main reasons for not taking part

  • Procedure done outside the UK
  • Procedure not on the registry protocol list or not agreed by the steering committee
  • Cannot give written informed consent

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Any patient undergoing a primary or revisional bariatric or metabolic endoscopic procedure
  • Age ≥ 18 years old
  • Able to give written informed consent

Who cannot take part

  • Any bariatric or metabolic endoscopic procedure performed outside the UK
  • Any bariatric or metabolic endoscopic procedure not currently listed within the registry protocol or agreed by the steering committee
  • Unable to provide written informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Where in United Kingdom

  • Cleveland Clinic LondonLondon, United KingdomContact: Benjamin Norton, MDTaking people

About the trial

What the trial wants to find out

In the UK alone, obesity is a major health problem with more than one quarter of adults estimated to be obese. Obesity promotes the development of many serious diseases including diabetes, heart disease, kidney disease, and increased risk of some cancers. Patients living with obesity also suffer from significant symptoms that impact their life including shortness of breath, back pain, poor mobility, and poor mental health. Traditional methods to help lose weight include low calorie diets and increased exercise. These may be effective in the short-term, but due to powerful biological mechanisms they are hard to maintain over the long-term and most individuals are unable to achieve normal weight. This means many people may need bariatric surgery that is highly effective at lowering body weight, but it is associated with complications and not all patients will want or be able to undergo surgery. This has led to the development of many new obesity treatments that are completed with an endoscope. An endoscope is a thin flexible tube that has a camera at the end. It is inserted through the mouth and into the stomach and small bowel. There are various procedures that can be done at the time of endoscopy that have been shown to be effective with a low number of side-effects. These are still relatively new compared to more traditional treatments and only a small number of doctors can perform them within the UK. Due to these limitations, the aim of this registry is to obtain real-world information on the safety and effectiveness of these procedures across the UK. The investigators hope over time this will improve the knowledge of clinicians about treating obesity with endoscopy and support future access and funding to these treatments.

The 3 groups in the trial

  • Primary bariatric endoscopic procedures

    Treatment: Endoscopic gastric suturing, Endoscopic gastric plication, and Intragastric balloon(s)

  • Revisional bariatric endoscopic procedures

    Treatment: Revisional gastroplasty and Transoral outlet reduction endoscopy (TORe)

  • Primary metabolic endoscopic procedures

    Treatment: Duodenal mucosal resurfacing (DMR)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A UK Registry for Metabolic and Bariatric Endoscopic Interventions
Plain-language title
Registry Tracking Endoscopic Treatments for Obesity and Type 2 Diabetes Across the UKGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06305208, who can take part
Record updated
15 March 2024